Search - tctmd.com

Displaying 101 - 120 of 519

Sort: Relevancy | Date

News Daily News

Análisis del Ensayo GRAVITAS: La ‘Paradoja del Fumador’ Desaparece con Dosis Dobles de Clopidogrel

Michael O'Riordan

February 28, 2016

News Conference News ISC 2016

To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds

Michael O'Riordan

February 23, 2016

News Industry News

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

February 22, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Conference News ISET 2016

Aspiration Thrombectomy Restores Flow in Patients With Peripheral Arterial Occlusion: PRISM Registry

Michael O'Riordan

February 09, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Shelley Wood

February 08, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

News Daily News

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

Todd Neale

February 04, 2016

News Daily News

分析显示中老年患者从机械主动脉瓣膜改用生物瓣膜可获改善

Caitlin E. Cox

January 20, 2016

News Daily News

Un Análisis Avala el Paso de Válvulas Aórticas Mecánicas a Bioprotésicas en Pacientes de Mediana Edad

Caitlin E. Cox

January 20, 2016

News Daily News

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Caitlin E. Cox

January 20, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

L.A. McKeown

December 10, 2015

News Industry News

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

December 07, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

Advertisement

Análisis del Ensayo GRAVITAS: La ‘Paradoja del Fumador’ Desaparece con Dosis Dobles de Clopidogrel

To Anticoagulate or Not? Debating Secondary Stroke Prevention in an A-fib Patient With Microbleeds

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Aspiration Thrombectomy Restores Flow in Patients With Peripheral Arterial Occlusion: PRISM Registry

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

分析显示中老年患者从机械主动脉瓣膜改用生物瓣膜可获改善

Un Análisis Avala el Paso de Válvulas Aórticas Mecánicas a Bioprotésicas en Pacientes de Mediana Edad

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

FDA Grants Go-Ahead for Low-Risk TAVR Study

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content